Automated description from the Alliance of Genome Resources (Release 7.2.0)
Predicted to enable LRR domain binding activity. Acts upstream of or within MyD88-dependent toll-like receptor 4 signaling pathway; MyD88-independent toll-like receptor signaling pathway; and positive regulation of tumor necrosis factor production. Is expressed in 1st branchial arch mandibular component mesenchyme; craniocervical region bone; and facial prominence. Orthologous to human LRRFIP2 (LRR binding FLII interacting protein 2).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.